Notes on patient capital.

Family capital works differently. When a family invests its own money, there is no one to return it to on a deadline. The question is never whether we need to exit this year, only whether the asset is still worth owning. That changes the conversation with a sponsor in a few practical ways.

First, it allows a business plan to run its course. Lease-up takes longer than expected; a renovation runs into permitting; a market softens for two years. A partner without a clock can wait for the plan to work rather than forcing a sale or an expensive recapitalisation at the worst moment.

Second, it simplifies decisions. A family office with a single decision-maker can say yes or no without layers of committee review. Sponsors know who they are talking to and can plan around a clear answer. That certainty is worth something when a seller is choosing between bidders, or a lender wants to know the equity is real.

Third, it aligns incentives over a longer horizon. A family thinking about the next generation cares about durability: sound tenants, sensible leverage, buildings and businesses that will age well. Those are usually the same things a good sponsor cares about, but they are not always what a short hold rewards.

None of this makes family capital free of discipline. Patient money that is careless is just slow money. The family still expects clear reporting, honest assumptions and a plan with real downside protection. Patience is a tool for letting good decisions work, not a reason to tolerate poor ones.

Family capital also has limits worth stating plainly. A single family cannot write unlimited cheques, may have narrower expertise than a large institution, and will often be more selective about who it works with. For the right deal and the right sponsor, though, those limits matter less than the stability it brings.

The best partnerships we see are built on matched expectations. A sponsor who wants a long-term holder, values a quick and clear answer, and is willing to share the downside honestly will usually find family capital a comfortable fit. That is the kind of partner we try to be.

A family office can participate on either side of that line. Investing as a limited partner is the familiar route. Participating at the GP level, by funding part of the sponsor's own commitment in exchange for a share of the promote, is less common and asks more of both parties.

Why would a family consider it? For the sponsor, GP capital can be hard to find. Lenders and limited partners often require the sponsor to invest meaningfully in each deal, and a growing firm may not have the balance sheet to keep pace with its pipeline. A patient partner at the sponsor level can bridge that gap without forcing the firm to give up control or take on investors with a short horizon.

For the family, a GP position means sharing in the economics that reward good execution, and seeing the business from the sponsor's side of the table. It also means taking on more risk. Promote is earned only if the deal clears its hurdle; if it does not, GP capital can be the first to feel the loss. That is why we approach these positions carefully.

Our questions are straightforward. Has the sponsor done this kind of deal before, through more than one market? Is the sponsor's own capital at risk alongside ours? Are the promote terms, hurdles and decision rights written down clearly, with no ambiguity about who decides what? And would we be content to hold the underlying asset if the plan took twice as long as expected?

We also care about how the relationship works day to day. A GP partner is closer to the operation than a limited partner, so reporting, communication and trust matter more. We do not want to run a sponsor's business; we want to understand it well enough to be useful and to be told early when something changes.

Not every sponsor wants a partner at the GP level, and not every deal suits one. Where it fits, though, the structure can align a family's long horizon with a sponsor's ambition in a way that benefits both. Every arrangement is different, and each is negotiated on its own terms.

The first is to take a full history. In medicine, much of the diagnosis comes from listening carefully before ordering a single test. In underwriting, the equivalent is understanding the people and the past before the spreadsheet: how the sponsor has handled difficult deals, why the seller is selling, what the tenant or customer has done over time. The model matters, but it is built on that history.

The second is to look for what does not fit. Clinicians learn that the detail out of place, the symptom that does not match the rest of the picture, is often the important one. In a deal, it might be an expense line that changed sharply, a lease clause that seems unusual, or an assumption that only works if everything goes right. Those details deserve the most attention, not the least.

The third is to think in terms of the worst plausible outcome, not the expected one. Before a procedure, a physician asks what could go wrong, how likely it is, and whether the patient could recover from it. An investor can ask the same questions: what happens if rents fall, if a key person leaves, if refinancing is not available on the terms assumed? If the answer is a loss the family could not accept, the expected case is irrelevant.

The fourth is to respect the second opinion. Good physicians seek out colleagues who will challenge their thinking. In investing, that means welcoming a sponsor who pushes back, consulting people who know an asset class better than we do, and being willing to change our minds when the evidence changes.

Finally, medicine teaches that doing nothing is sometimes the right treatment. Not every symptom calls for an intervention, and not every opportunity calls for capital. Waiting, gathering more information or declining entirely are legitimate decisions. A family office free of pressure to deploy capital can make them without apology.

None of this is a formula, and training in one field does not guarantee good judgement in another. But the habits of careful listening, attention to anomalies, respect for the downside and humility about one's own view are useful anywhere decisions carry real consequences. They shape how we approach every opportunity we see.